Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Gene

IFNG

2 articles · Resources: NCBI Gene, OncoKB

Clinical · Molecular biology

Spatial transcriptomics identifies tumor-intrinsic and stromal programs associated with immune exclusion in NSCLC

Guegan JP, Bonhomme B, Peyraud F, et al.

Signal transduction and targeted therapy

This study investigates the molecular and spatial mechanisms underlying CD8+ T-cell immune exclusion in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint blockade. Spatial CD8+ exclusion, defined by stroma-restricted T cells that fail to penetrate tumor nests, correlates with reduced objective response rates and shorter progression-free survival. Multi-omic integration—including GeoMx spatial transcriptomics, multiplex immunofluorescence, and bulk transcriptomics—revealed tumor-intrinsic defects in antigen-presentation machinery, specifically involving HLA class I genes and TAP1, along with uncoupled IFN-γ signaling. Concurrently, the excluded stroma is characterized by myofibroblastic cancer-associated fibroblasts and collagen-dense barriers, accompanied by CD8+ T cells displaying impaired metabolic activation and lower TCR diversity rather than classic exhaustion.

Clinical

Molecular architecture of the tumor microenvironment caused by BRCA1 and BRCA2 somatic mutations in human lung adenocarcinoma

Liao G, Yang X, Liu Q, et al.

eLife

This study characterized the molecular architecture of the tumor microenvironment (TME) in lung adenocarcinoma (LUAD) with somatic BRCA1/2 mutations, using single-cell sequencing and multi-omics data. BRCA1/2 mutations are linked to increased genomic instability and poor prognosis, yet predict better clinical outcomes with immune checkpoint blockade (ICB) treatment. BRCA1 mutations correlate with an upregulated type I IFN/IFN-γ signature and CD8+ T cell activation, while BRCA2 mutations are associated with inflammatory responses and enhanced MHC-II antigen presentation, influencing CD4+ T cell differentiation. The study also identified tissue-resident memory T cell (Trm) subsets as predictors of ICB response and found that a cancer-promoting program activated by BRCA1 is vulnerable to histone deacetylase inhibitors.